Long-Term OS for Patients With Advanced NSCLC Enrolled in the KEYNOTE-001 Study of Pembrolizumab

Suresh Ramalingam, Rina Hui, Leena Gandhi, Enric Carcereny, Enriqueta Felip, Myung-Ju Ahn, Joseph P Eder, Ani S Balmanoukian, Natasha Leighl, Charu Aggarwal, Leora Horn, Amita Patnaik, Gary W Middleton, Matthew Gubens, Matthew Hellmann, Jean-Charles Soria, Gregory M Lubiniecki, Jin Zhang, Bilal Piperdi, Edward B Garon

Research output: Contribution to journalAbstractpeer-review

Original languageEnglish
Article numberP2.39
Pages (from-to)S241-S242
JournalJournal of Thoracic Oncology
Issue number10 (Supplement)
Early online date22 Sept 2016
Publication statusPublished - Oct 2016
EventIASLC 7th Latin American Conference on Lung Cancer - Panama City, Panama, United States
Duration: 25 Aug 201627 Aug 2016


  • Advanced non-small cell lung cancer
  • PD-1 inhibition
  • Pembrolizumab
  • PD-L1

Cite this